SAN MATEO, Calif.--(BUSINESS WIRE)--
Model
N, Inc. (NYSE: MODN), the leading provider of cloud-based revenue
management solutions to life sciences and high tech companies, today
announced it has partnered with BPI Technologies Corporation, a
recognized leader in revenue recognition solutions, to help our
customers make faster, smarter, better-informed business decisions, and
maximize profit.
The Model N and BPI partnership will provide customers seamless
integration that combines comprehensive structural and transactional
data across commercial, government, and chargeback channels from Model N
with a sophisticated gross-to-net (GTN) revenue recognition offering
from BPI. Together, the Model N BPI Gross-to-Net solution will provide
customers with fast and complete visibility into pre-deal analysis, the
true price of products, true net revenue, accurate accruals, full audit
reporting, and reliable forecasts that are critical to pharmaceutical
and medical technology manufacturers.
“We are very happy to announce the partnership of our gross-to-net
revenue application with the Model N revenue execution platform,” said
Richard L. Burcham, chief executive officer at BPI Technologies
Corporation. “Based on new data from IQVIA, manufacturers of brand-name
drugs in 2017 reduced list price revenues by an astonishing $153
billion---a new high and twice what it was only 5 years ago. Our
combined solution will help our customers achieve higher net revenue and
reduce the risk associated with gross-to-net forecasting, accrual
management and reporting.”
By driving top-line growth through Model N’s revenue execution platform,
and by understanding the true prices and revenues together with
sophisticated “what if” analysis within a mature gross-to-net joint
solution, customers will be able to make better-informed business
decisions to achieve both maximum growth and increased profitability.
“We are thrilled to be working with BPI to combine Model N’s trusted
transaction data sets with BPI’s advanced analytics tools,” said Jason
Blessing, president and chief executive officer at Model N. “Together we
will provide complete gross-to-net visibility in near-real-time at each
step of the revenue lifecycle. This further builds upon Model N’s
position as a critical solution provider for the healthcare ecosystem.”
About Model N
Model N is the leader in revenue management solutions. Driving
mission-critical business processes such as contract and rebate
management, business intelligence, and regulatory compliance, Model N
solutions transform the revenue lifecycle from a series of disjointed
operations into a strategic end-to-end process. With deep industry
expertise, Model N supports the complex business needs of the world’s
leading brands in pharmaceutical, medical device, high tech,
manufacturing and semiconductors across more than 120 countries,
including Pfizer, AstraZeneca, Sanofi, Gilead, Abbott, Stryker, AMD,
Micron, Seagate, STMicroelectronics, NXP, Sesotech, and Southern States.
For more information, visit www.modeln.com.
Model N® is the registered trademark of Model N, Inc. Any other company
names mentioned are the property of their respective owners and are
mentioned for identification purposes only.
About BPI
BPI is a forward-looking company and believes in investing in a vision
of today that can become a reality tomorrow. Transformation of
Gross-to-Net processes is one such area of interest. From business
models to technology, BPI’s gross-to-net solution is helping companies
achieve end-to-end transformation of GTN across all channels of their
business. Key to transformation is the flexibility and scalability to
configure our application to address the ever-changing complexity of the
commercial and regulatory environments.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181115005294/en/
Sherri Walkenhorst,
801-373-7888
swalkenhorst@modeln.com
Source: Model N, Inc.